Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Arts and Science collaborate in creating sustainable futures

2016-03-16

Creating a future where living green is the status quo: Dr Keith Armstrong
Photo: Lihlumelo Toyana

In creating partnerships across disciplines, mankind gains a deeper understanding of how to create the future. This is the premise upon which Dr Keith Armstrong bases his research and experimental art. Dr Armstrong is an Australian Hybrid Media artist and a Senior Research Fellow at Queensland University of Technology in Australia.

Artists that make things happen

“My journey has shifted from an artist that makes things to an artist that makes things happen,” he said at the New Futures: Innovations in Arts and Science public talk recently at Oliewenhuis Art Museum. The talk, organised by the Johannes Stegmann Art Gallery, was part of a series of artistic projects presented by the Programme for Innovation in Arts and Development (PIAD). This initiative is spearheaded by the UFS and Vrystaat Arts Festival, kindly supported by The Andrew W. Mellon Foundation.

Dr Angus Hervey – an Australian writer, technologist and science communicator– was also a speaker at the event. Dr Hervey is a co-founder of Future Crunch, a platform for intelligent, optimistic thinking about the future. He strongly shares Dr Armstrong’s passion and viewpoints.

Dr Armstrong’s work is motivated by social and ecological justice. His non-traditional research and more than 60 artworks serve to evoke audiences to create sustainable futures.

Building the future

Dr Armstrong is in the process of making “things happen” in informal settlements across the Free State by means of his Re-Future project. The project brings together sustainability, community development, and creative action. It moves away from conventional art practices and instead offer a platform to rethink and therefore re-future our practices of sustainability.

The Re-Future project has been initiated through a collaboration between the Johannes Stegmann Art Gallery, the UFS Centre for Development Support (CDS) and Qala Phelang Tala (QPT) and the Vrystaat Art Festival.

According to Anita Venter, a lecturer at CDS and founder of QPT, empowerment is at the centre of the artist-initiated, yet community-controlled project. “It gives a new direction and new hope to the community,” she said.

For more information
Angela de Jesus, dejesusav@ufs.ac.za or +27(0)51 401 2706

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept